B Lymphocyte News and Research

RSS
The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

The possible immune-mediated mechanisms causing CNS alterations during and post-acute SARS-CoV-2 infection

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Researchers compare the development and persistence of antibody and T-cell responses elicited by the mRNA BNT162b2 vaccine or SARS-CoV-2 infection

Type I interferons play crucial role in fending off SARS-CoV-2

Type I interferons play crucial role in fending off SARS-CoV-2

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

Exploring cross-neutralizing anti-SARS-CoV-2 antibody responses among the general population

Exploring cross-neutralizing anti-SARS-CoV-2 antibody responses among the general population

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

Combined COVID-19 vaccination regimen found to induce more potent anti-SARS-CoV-2 antibodies

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

A study of SARS-CoV-2-mRNA booster vaccinations in immunocompromised patients

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

New finding may aid in development of vaccines against future animal-to-human viral diseases

New finding may aid in development of vaccines against future animal-to-human viral diseases

Severe COVID-19 patients have significantly higher NK and T cell frequency

Severe COVID-19 patients have significantly higher NK and T cell frequency

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

Study: Covid-19 vaccine-elicited immune cells persist six months after vaccination

The case for vaccinating children under 12 against COVID-19

The case for vaccinating children under 12 against COVID-19

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

HSS study provides insight into real-world medication use for treatment of psoriatic arthritis

Automated method shows predictive power for COVID-19 in-hospital mortality

Automated method shows predictive power for COVID-19 in-hospital mortality

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

Potential link between SARS-CoV-2 infection and secondary occurrence of anti-NMDAR encephalitis

CAR-T cell treatment's efficacy in hematological malignancies predicted by epigenetics

CAR-T cell treatment's efficacy in hematological malignancies predicted by epigenetics

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis

Immune responses to SARS-CoV-2 infection and vaccination in patients with multiple sclerosis